Tenormin

Atenolol (Tenormin), Can Cause Bradycardia in Infant Breast-Fed

In February. 9, approved corrections in safety, marking for atenolol intravenous injection and tablet (Tenormin, made AstraZeneca Pharmaceuticals LP) to be warned risk hypoglycemia and bradycardia in neonates born mother operated by medicine in sort or while breast-nursing.

That is to say, prescriptions distributed in general as atenolol 100 mg. tablet are considered that will be other product than that portioned for Pharmaceuticalses AstraZeneca’ mg. tablets Tenormin 100 even though atenolol - an active component in Tenormin.
AstraZeneca - main international healthcare deal (the business) concerned with by study, development, production and marketing the pharmaceuticalses of the prescription and supply healthcare services. This - one of worldwide leading pharmaceutical companies with healthcare sellout on $21.4 and presenting is positioned in sellout gastrointestinal, heartily, respiratory, oncology and products neuroscience. AstraZeneca is SPECIFIED in Index milk-DZHONSA Sustainability (Global), as well as Index FTSE4Good. AstraZeneca HAS more, than 40 experiences of the years in cardiovascular medicine and aims to enlarge lifespan and perfect the quality to lifes reducing risk, spreading and influence cardiovascular disease. AstraZeneca HAS exhausting cardiovascular briefcase including CRESTOR(R), Atacand(R), ZESTRIL(R), TENORMIN(R), SELOKEN(R) ZOK /TOPROL-XL(R) and Plendil(R). This heritage is complemented by progressive conveyor including first spoken direct thrombin inhibitor, Exanta(R), and new processing for type 2 diabeteses / metabolic syndrome, GALIDA(R).
AstraZeneca - main international healthcare deal (the business) concerned with by study, development, production and marketing the pharmaceuticalses of the prescription and supply healthcare services. This - one of the top five pharmaceutical companies in the world with healthcare sellout on $18.8 and presenting is positioned in sellout gastrointestinal, oncology, heartily, neuroscience and products respiratory. AstraZeneca is SPECIFIED in Index milk-DZHONSA Sustainability (Global and European), as well as Index FTSE4Good. AstraZeneca HAS more, than 40 experiences of the years in cardiovascular medicine and aims to enlarge lifespan and perfect the quality to lifes reducing risk, spreading and influence cardiovascular disease. AstraZeneca HAS exhausting cardiovascular briefcase including briefcase including CRESTOR, Atacand, Zestril, Tenormin, SELOKEN ZOK/TOPROL-XL and Plendil*. This heritage is complemented by progressive conveyor including first spoken direct thrombin inhibitor, Exanta*, and new processing for type 2 diabeteses / metabolic syndrome, GALIDA *.

CRESTOR, Atacand, Zestril, Tenormin, SELOKEN ZOK/TOPROL-XL, Plendil, Exanta And GALIDA - a trademarks of the group AstraZeneca companies.

Filed under Health |